Clinical Trials Directory

Trials / Completed

CompletedNCT03846726

Treatment Strategy for Rectal Cancer Patients With Complete Clinical Response

Watch-and-wait Approach Versus Surgical Resection for Rectal Cancer Patients With Complete Clinical Response After Chemoradiotherapy: a Multi-center Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
513 (actual)
Sponsor
Yuan-hong Gao · Academic / Other
Sex
All
Age
16 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This was a propensity-score matched observational analysis, comparing the oncological outcome of surgical resection vs watch and wait apporach for rectal cancer patients with a cCR.

Detailed description

Pathologically confirmed stage II/III rectal adenocarcinoma patients who received neoadjuvant chemoradiotherapy followed by a clinical complete response from the year 2010 to 2018 were included. Sequential subjects were identified from a prospective maintained database in the Sun Yat-sen University Cancer Center. Clinical experts on rectal cancer from other 5 regional medical centers in China were also invited to participate, and provided data of cCR patients. Standardized forms for data collection were sanded to researchers in each center. Patients received radical resection will constituted our surgery group. Those refused surgery constituted the observation group who went on with the watch and wait approach. A propensity-score matched observational analysis will be used to compare the oncological outcome of these two groups.

Conditions

Interventions

TypeNameDescription
PROCEDUREstandard TME surgeryradical resection for rectal cancer

Timeline

Start date
2018-01-01
Primary completion
2019-02-28
Completion
2019-02-28
First posted
2019-02-20
Last updated
2023-04-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03846726. Inclusion in this directory is not an endorsement.